Marcel Bally
48Patents
33h-index
39Co-inventors
85Inventor score
Filing activity: Jul 26, 1985 → Jul 27, 2018
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5595756A | Liposomal compositions for enhanced retention of bioactive agents | Human Necessities | 600 | Expired |
| US5976567A | Lipid-nucleic acid particles prepared via a hydrophobic lipid-nucleic acid complex intermediate and use for gene transfer | Human Necessities | 342 | Expired |
| US6815432B2 | Methods for encapsulating plasmids in lipid bilayers | Emerging Cross-Sectional Technologies | 303 | Expired |
| US5705385A | Lipid-nucleic acid particles prepared via a hydrophobic lipid-nucleic acid complex intermediate and use for gene transfer | Chemistry; Metallurgy | 267 | Expired |
| US5981501A | Methods for encapsulating plasmids in lipid bilayers | Emerging Cross-Sectional Technologies | 265 | Expired |
| US5008050A | Extrusion technique for producing unilamellar vesicles | Emerging Cross-Sectional Technologies | 239 | Expired |
| US6534484B1 | Methods for encapsulating plasmids in lipid bilayers | Emerging Cross-Sectional Technologies | 220 | Expired |
| US7422902B1 | Lipid-nucleic acid particles prepared via a hydrophobic lipid-nucleic acid complex intermediate and use for gene transfer | Emerging Cross-Sectional Technologies | 212 | Expired |
| US5077056A | Encapsulation of antineoplastic agents in liposomes | Emerging Cross-Sectional Technologies | 204 | Expired |
| US4880635A | Dehydrated liposomes | Human Necessities | 199 | Expired |
| US5543152A | Sphingosomes for enhanced drug delivery | Human Necessities | 187 | Expired |
| US6586410B1 | Lipid-nucleic acid particles prepared via a hydrophobic lipid-nucleic acid complex intermediate and use for gene transfer | Emerging Cross-Sectional Technologies | 185 | Expired |
| US5399331A | Method for protein-liposome coupling | Human Necessities | 162 | Expired |
| US5741516A | Sphingosomes for enhanced drug delivery | Human Necessities | 155 | Expired |
| US6858224B2 | Method of preventing aggregation of a lipid:nucleic acid complex | Emerging Cross-Sectional Technologies | 145 | Expired |
| US4975282A | Multilamellar liposomes having improved trapping efficiencies | Human Necessities | 126 | Expired |
| US5059421A | Preparation of targeted liposome systems of a defined size distribution | Human Necessities | 112 | Expired |
| US5736155A | Encapsulation of antineoplastic agents in liposomes | Human Necessities | 101 | Expired |
| US5795589A | Liposomal antineoplastic agent compositions | Emerging Cross-Sectional Technologies | 80 | Expired |
| US5814335A | Sphingosomes for enhanced drug delivery | Human Necessities | 79 | Expired |
| US5409704A | Liposomes comprising aminoglycoside phosphates and methods of production and use | Emerging Cross-Sectional Technologies | 75 | Expired |
| US5478860A | Stable microemulsions for hydrophobic compound delivery | Human Necessities | 70 | Expired |
| US5965542A | Use of temperature to control the size of cationic liposome/plasmid DNA complexes | Human Necessities | 61 | Expired |
| US5922350A | Methods of dehydrating, storing and rehydrating liposomes | Human Necessities | 59 | Expired |
| US4885172A | Composition for targeting, storing and loading of liposomes | Human Necessities | 57 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.